tradingkey.logo
tradingkey.logo
Search

Cumberland Pharmaceuticals Inc

CPIX
Add to Watchlist
7.320USD
+0.130+1.81%
Close 09-18 16:00ET
109.83MMarket Cap
LossP/E TTM

Cumberland Pharmaceuticals Inc (CPIX) Revenue Performance

Updated: Mar 31, 2026

By Business

Annual
Annual
Quarterly
Sancuso
Kristalose
Vibativ
Caldolor
Other
Talicia
Acetadote
RediTrex
Omeclamox-Pak
Vaprisol
Ethyol
Totect
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
Sancuso
11.91M(26.74%)
9.01M(23.78%)
8.10M(20.47%)
13.21M(31.43%)
--(--)
--(--)
--(--)
--(--)
Kristalose
10.54M(23.68%)
15.32M(40.44%)
15.98M(40.41%)
15.21M(36.19%)
15.99M(45.64%)
15.57M(43.44%)
12.90M(27.13%)
12.06M(29.59%)
Vibativ
9.48M(21.30%)
7.16M(18.91%)
8.81M(22.28%)
7.49M(17.82%)
11.70M(33.40%)
10.87M(30.33%)
8.69M(18.29%)
5.08M(12.46%)
Caldolor
4.66M(10.47%)
4.96M(13.10%)
4.33M(10.96%)
4.83M(11.49%)
4.97M(14.18%)
5.34M(14.89%)
5.22M(10.99%)
5.00M(12.28%)
Other
4.13M(9.27%)
1.33M(3.51%)
2.04M(5.16%)
1.33M(3.17%)
--(--)
--(--)
1.98M(4.17%)
540.93K(1.33%)
Talicia
3.31M(7.44%)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
Acetadote
508.17K(1.14%)
185.18K(0.49%)
458.76K(1.16%)
501.04K(1.19%)
850.99K(2.43%)
1.87M(5.23%)
3.82M(8.05%)
4.28M(10.52%)
RediTrex
11.39K(0.03%)
90.24K(0.24%)
-341.89K(-0.86%)
-126.73K(-0.30%)
55.32K(0.16%)
856.66K(2.39%)
--(--)
--(--)
Omeclamox-Pak
-10.44K(-0.02%)
-3.08K(-0.01%)
20.03K(0.05%)
29.14K(0.07%)
-388.66K(-1.11%)
257.09K(0.72%)
837.83K(1.76%)
623.30K(1.53%)
Vaprisol
-18.35K(-0.04%)
-174.54K(-0.46%)
151.34K(0.38%)
-447.70K(-1.07%)
1.86M(5.31%)
1.08M(3.01%)
936.62K(1.97%)
1.76M(4.33%)
Ethyol
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
12.77M(26.88%)
10.55M(25.88%)
Totect
--(--)
--(--)
--(--)
--(--)
--(--)
--(--)
369.91K(0.78%)
850.97K(2.09%)
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.